Research ExplorerPublicationsPrognostic factors and treatment options in patients with le...

Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.

Standard

Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. / Oechsle, Karin; Lange-Brock, Victoria; Krüll, Andreas; Bokemeyer, Carsten; De Wit, Maike.

In: J CANCER RES CLIN, Vol. 136, No. 11, 11, 2010, p. 1729-1735.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Oechsle, K, Lange-Brock, V, Krüll, A, Bokemeyer, C & De Wit, M 2010, 'Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.', J CANCER RES CLIN, vol. 136, no. 11, 11, pp. 1729-1735. <http://www.ncbi.nlm.nih.gov/pubmed/20204406?dopt=Citation>

APA

Oechsle, K., Lange-Brock, V., Krüll, A., Bokemeyer, C., & De Wit, M. (2010). Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J CANCER RES CLIN, 136(11), 1729-1735. [11]. http://www.ncbi.nlm.nih.gov/pubmed/20204406?dopt=Citation

Vancouver

Oechsle K, Lange-Brock V, Krüll A, Bokemeyer C, De Wit M. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J CANCER RES CLIN. 2010;136(11):1729-1735. 11.

Bibtex

@article{9731ed72b43a4acc9055a127ec51f566,
title = "Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.",
abstract = "Leptomeningeal metastases (LM) are associated with very poor prognosis and data on outcome are limited. We evaluated prognostic factors and treatment options in patients (pts) with LM of different malignancies in a single center experience.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Prognosis, Survival Analysis, Combined Modality Therapy, Proportional Hazards Models, Retrospective Studies, Neoplasms drug therapy, Hematologic Neoplasms drug therapy, Lung Neoplasms drug therapy, Melanoma drug therapy, Meningeal Carcinomatosis drug therapy, Neoplasm Metastasis drug therapy, Adult, Humans, Male, Aged, Female, Middle Aged, Adolescent, Prognosis, Survival Analysis, Combined Modality Therapy, Proportional Hazards Models, Retrospective Studies, Neoplasms drug therapy, Hematologic Neoplasms drug therapy, Lung Neoplasms drug therapy, Melanoma drug therapy, Meningeal Carcinomatosis drug therapy, Neoplasm Metastasis drug therapy",
author = "Karin Oechsle and Victoria Lange-Brock and Andreas Kr{\"u}ll and Carsten Bokemeyer and {De Wit}, Maike",
year = "2010",
language = "Deutsch",
volume = "136",
pages = "1729--1735",
journal = "J CANCER RES CLIN",
issn = "0171-5216",
publisher = "Springer",
number = "11",

}

RIS

TY - JOUR

T1 - Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.

AU - Oechsle, Karin

AU - Lange-Brock, Victoria

AU - Krüll, Andreas

AU - Bokemeyer, Carsten

AU - De Wit, Maike

PY - 2010

Y1 - 2010

N2 - Leptomeningeal metastases (LM) are associated with very poor prognosis and data on outcome are limited. We evaluated prognostic factors and treatment options in patients (pts) with LM of different malignancies in a single center experience.

AB - Leptomeningeal metastases (LM) are associated with very poor prognosis and data on outcome are limited. We evaluated prognostic factors and treatment options in patients (pts) with LM of different malignancies in a single center experience.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Prognosis

KW - Survival Analysis

KW - Combined Modality Therapy

KW - Proportional Hazards Models

KW - Retrospective Studies

KW - Neoplasms drug therapy

KW - Hematologic Neoplasms drug therapy

KW - Lung Neoplasms drug therapy

KW - Melanoma drug therapy

KW - Meningeal Carcinomatosis drug therapy

KW - Neoplasm Metastasis drug therapy

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Adolescent

KW - Prognosis

KW - Survival Analysis

KW - Combined Modality Therapy

KW - Proportional Hazards Models

KW - Retrospective Studies

KW - Neoplasms drug therapy

KW - Hematologic Neoplasms drug therapy

KW - Lung Neoplasms drug therapy

KW - Melanoma drug therapy

KW - Meningeal Carcinomatosis drug therapy

KW - Neoplasm Metastasis drug therapy

M3 - SCORING: Zeitschriftenaufsatz

VL - 136

SP - 1729

EP - 1735

JO - J CANCER RES CLIN

JF - J CANCER RES CLIN

SN - 0171-5216

IS - 11

M1 - 11

ER -